NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

DOI Full Paper Access

374

Citations

8

References

2023

Year

Zev A. Wainberg, Davide Melisi, Teresa Macarulla, Roberto Pazo-Cid, Sreenivasa R Chandana, Christelle de la Fouchardière, Andrew Dean, Igor Kišš, Woo Jin Lee, Thorsten Oliver Goetze,

References

	Year	Citations

Page 1